tradingkey.logo
搜尋

DarioHealth Corp

DRIO
添加自選
7.280USD
+0.570+8.49%
收盤 07/02, 13:00美東報價延遲15分鐘
53.14M總市值
虧損本益比TTM

DarioHealth Corp

7.280
+0.570+8.49%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+8.49%

5天

+3.56%

1月

-4.21%

6月

-30.80%

今年開始到現在

-36.03%

1年

-48.35%

關鍵數據
6.895今開
8.000最高
61.00K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.84%換手率
6.750昨收
6.895最低
333.82K成交額
虧損本益比靜
0.85市淨率
0.00%股息率 TTM
-37.22%ROA
17.74452週最高
3.84量比
-40.98M淨利潤
7.30M總股本
-13.8842每股盈餘TTM
1.10Beta
-92.87%ROE
5.93552週最低
16.37%振幅
57.31%毛利率
53.14M總市值
-1.69回報/風險
6.62%風險率

TradingKey DarioHealth Corp股票評分

單位: USD 更新時間: 2026-07-02

操作建議

DarioHealth Corp當前公司基本面數據相對健康,增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名105/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為18.50。中期看,股價處於上升通道。近一個月,市場表現一般,但技術面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

DarioHealth Corp評分

相關信息

行業排名
105 / 204
全市場排名
253 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

DarioHealth Corp亮點

亮點風險
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
業績增長期
公司處於發展階段,最新年度總收入22.36M美元
估值高估
公司最新PE估值-0.52,處於3年歷史高位
機構減倉
最新機構持股782.90K股,環比減少22.05%

分析師目標

基於 4 分析師
買入
評級
18.500
目標均價
+174.07%
漲幅空間

DarioHealth Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

DarioHealth Corp簡介

DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
公司代碼DRIO
公司DarioHealth Corp
CEORaphael (Erez)
網址https://shop.mydario.com/

常見問題

DarioHealth Corp(DRIO)的當前股價是多少?

DarioHealth Corp(DRIO)的當前股價是 7.28。

DarioHealth Corp 的股票代碼是什麼?

DarioHealth Corp的股票代碼是DRIO。

DarioHealth Corp股票的52週最高點是多少?

DarioHealth Corp股票的52週最高點是17.74。

DarioHealth Corp股票的52週最低點是多少?

DarioHealth Corp股票的52週最低點是5.93。

DarioHealth Corp的市值是多少?

DarioHealth Corp的市值是53.14M。

現在DarioHealth Corp(DRIO)的股票是買入、持有還是賣出?

根據分析師評級,DarioHealth Corp(DRIO)的總體評級為買入,目標價格為18.50。

DarioHealth Corp(DRIO)股票的每股收益(EPS TTM)是多少

DarioHealth Corp(DRIO)股票的每股收益(EPS TTM)是-15.50。